300639 凯普生物
已收盘 10-30 15:00:00
资讯
新帖
简况
凯普生物（300639）10月28日主力资金净卖出750.06万元
证券之星 · 10-29
凯普生物（300639）10月28日主力资金净卖出750.06万元
凯普生物(300639.SZ)发布前三季度业绩，归母净利润6992.66万元，同比增长154.77%
智通财经 · 10-27
凯普生物(300639.SZ)发布前三季度业绩，归母净利润6992.66万元，同比增长154.77%
凯普生物(300639)9月30日股东户数3.44万户，较上期增加0.7%
证券之星 · 10-27
凯普生物(300639)9月30日股东户数3.44万户，较上期增加0.7%
凯普生物（300639）10月22日主力资金净卖出493.95万元
证券之星 · 10-23
凯普生物（300639）10月22日主力资金净卖出493.95万元
股市必读：凯普生物新发布《关于回购股份结果暨股份变动的公告》
证券之星 · 10-23
股市必读：凯普生物新发布《关于回购股份结果暨股份变动的公告》
凯普生物（300639）披露回购股份结果暨股份变动的公告，10月21日股价下跌2.56%
证券之星 · 10-21
凯普生物（300639）披露回购股份结果暨股份变动的公告，10月21日股价下跌2.56%
凯普生物（300639）10月19日主力资金净卖出48.64万元
证券之星 · 10-20
凯普生物（300639）10月19日主力资金净卖出48.64万元
凯普生物最新公告：全资子公司取得医疗器械注册证书
证券之星 · 10-11
凯普生物最新公告：全资子公司取得医疗器械注册证书
股市必读：凯普生物新发布《关于2026年以集中竞价交易方式回购公司股份的进展公告》
证券之星 · 10-08
股市必读：凯普生物新发布《关于2026年以集中竞价交易方式回购公司股份的进展公告》
凯普生物（300639）9月29日主力资金净卖出1332.77万元
证券之星 · 09-30
凯普生物（300639）9月29日主力资金净卖出1332.77万元
凯普生物（300639）9月28日主力资金净卖出1160.57万元
证券之星 · 09-29
凯普生物（300639）9月28日主力资金净卖出1160.57万元
凯普生物(300639)9月18日股东户数3.42万户，较上期增加0.97%
证券之星 · 09-22
凯普生物(300639)9月18日股东户数3.42万户，较上期增加0.97%
凯普生物：截至2026年9月18日，公司股东总户数为34,181户
证券之星 · 09-22
凯普生物：截至2026年9月18日，公司股东总户数为34,181户
凯普生物：截至2026年9月10日，公司股东总户数为33,853户
证券之星 · 09-16
凯普生物：截至2026年9月10日，公司股东总户数为33,853户
股市必读：凯普生物新发布《关于参加2026年广东辖区投资者集体接待日暨辖区上市公司中报业绩说明会活动的公告》
证券之星 · 09-10
股市必读：凯普生物新发布《关于参加2026年广东辖区投资者集体接待日暨辖区上市公司中报业绩说明会活动的公告》
股市必读：凯普生物(300639)股东户数3.41万户，较上期减少4.31%
证券之星 · 09-07
股市必读：凯普生物(300639)股东户数3.41万户，较上期减少4.31%
凯普生物(300639)8月31日股东户数3.41万户，较上期减少4.31%
证券之星 · 09-04
凯普生物(300639)8月31日股东户数3.41万户，较上期减少4.31%
凯普生物：截至2026年8月31日，公司股东总户数为34,098户
证券之星 · 09-04
凯普生物：截至2026年8月31日，公司股东总户数为34,098户
凯普生物（300639）披露2026年以集中竞价交易方式回购公司股份的进展公告，8月31日股价下跌2.15%
证券之星 · 08-31
凯普生物（300639）披露2026年以集中竞价交易方式回购公司股份的进展公告，8月31日股价下跌2.15%
凯普生物(300639)8月20日股东户数3.56万户，较上期增加1.91%
证券之星 · 08-26
凯普生物(300639)8月20日股东户数3.56万户，较上期增加1.91%
公司概况
公司名称：
广东凯普生物科技股份有限公司
所属行业：
医药制造业
上市日期：
2017-04-12
主营业务：
广东凯普生物科技股份有限公司的主营业务是分子诊断产品、医学检验服务、医疗大健康服务。公司的主要产品是肿瘤检测、传染病检测、妇幼健康管理、出生缺陷防控、个体化精准用药。公司系宫颈癌筛查--HPV检测的先行者、倡导者，长期深耕妇科肿瘤早筛赛道，构建了国内品类最全、技术迭代领先的HPV检测产品矩阵，持续巩固宫颈癌早筛领域龙头地位，多款核心产品具备行业标杆性优势：HPV21分型检测试剂盒是我国首个取得新药证书的HPV检测产品，核心专利荣获第十八届中国专利金奖。
发行价格：
18.39
{"stockData":{"symbol":"300639","market":"SZ","secType":"STK","nameCN":"凯普生物","latestPrice":5.73,"timestamp":1793343795000,"preClose":5.83,"halted":0,"volume":16614688,"delay":0,"changeRate":-0.0172,"floatShares":630000000,"shares":647000000,"eps":0.1032,"marketStatus":"已收盘","change":-0.1,"latestTime":"10-30 15:00:00","open":5.75,"high":6.02,"low":5.63,"amount":96097500,"amplitude":0.0669,"askPrice":5.73,"askSize":56,"bidPrice":5.72,"bidSize":121,"shortable":0,"etf":0,"ttmEps":0.1032,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1793583000000},"marketStatusCode":5,"adr":0,"adjPreClose":5.83,"symbolType":"stock","openAndCloseTimeList":[[1793323800000,1793331000000],[1793336400000,1793343600000]],"highLimit":6.41,"lowLimit":5.25,"ibTradeSell":false,"ibTradeBuySell":false,"totalEquity":646500674,"isCdr":false,"pbRate":1.02,"roa":"--","peRate":55.523256,"roe":"1.86%","epsLYR":-0.21,"committee":-0.174779,"marketValue":3704000000,"turnoverRate":0.0264,"status":1,"floatMarketCap":3611000000},"requestUrl":"/m/hq/s/300639/wiki","defaultTab":"wiki","newsList":[{"id":"2679274449","title":"凯普生物（300639）10月28日主力资金净卖出750.06万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2679274449","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2679274449?lang=zh_cn&edition=full","pubTime":"2026-10-29 09:08","pubTimestamp":1793236092,"startTime":"0","endTime":"0","summary":"证券之星消息，截至2026年10月28日收盘，凯普生物报收于6.01元，上涨7.13%，换手率4.07%，成交量25.63万手，成交额1.51亿元。近5日资金流向一览见下表：凯普生物融资融券信息显示，融资方面，当日融资买入1008.58万元，融资偿还1423.45万元，融资净偿还414.87万元。凯普生物主营业务：围绕人民健康开展,属于生物医药领域中的体外诊断领域,是分子诊断产品和服务的一体化供应商。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026102900015850.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","300639","BK0042","BK0046","BK0132"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2678103649","title":"凯普生物(300639.SZ)发布前三季度业绩，归母净利润6992.66万元，同比增长154.77%","url":"https://stock-news.laohu8.com/highlight/detail?id=2678103649","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2678103649?lang=zh_cn&edition=full","pubTime":"2026-10-27 21:39","pubTimestamp":1793108381,"startTime":"0","endTime":"0","summary":"智通财经APP讯，凯普生物(300639.SZ)发布2026年三季度报告，前三季度，公司实现营业收入4.58亿元，同比下降5.76%。归属于上市公司股东的净利润6992.66万元，同比增长154.77%。归属于上市公司股东的扣除非经常性损益的净利润4853.17万元，同比增长135.85%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1513668.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["300639"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2678175750","title":"凯普生物(300639)9月30日股东户数3.44万户，较上期增加0.7%","url":"https://stock-news.laohu8.com/highlight/detail?id=2678175750","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2678175750?lang=zh_cn&edition=full","pubTime":"2026-10-27 18:53","pubTimestamp":1793098394,"startTime":"0","endTime":"0","summary":"证券之星消息，近日凯普生物披露，截至2026年9月30日公司股东户数为3.44万户，较9月18日增加238.0户，增幅为0.7%。在医疗器械行业个股中，凯普生物股东户数高于行业平均水平，截至9月30日，医疗器械行业平均股东户数为2.08万户。从股价来看，2026年9月18日至2026年9月30日，凯普生物区间涨幅为7.12%，在此期间股东户数增加238.0户，增幅为0.7%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026102700035409.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0132","BK0042","BK0046","BK0239","300639"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2677915154","title":"凯普生物（300639）10月22日主力资金净卖出493.95万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2677915154","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2677915154?lang=zh_cn&edition=full","pubTime":"2026-10-23 09:18","pubTimestamp":1792718308,"startTime":"0","endTime":"0","summary":"证券之星消息，截至2026年10月22日收盘，凯普生物报收于5.73元，下跌6.07%，换手率2.67%，成交量16.83万手，成交额9907.45万元。近5日资金流向一览见下表：凯普生物融资融券信息显示，融资方面，当日融资买入711.71万元，融资偿还1159.78万元，融资净偿还448.07万元。凯普生物主营业务：围绕人民健康开展,属于生物医药领域中的体外诊断领域,是分子诊断产品和服务的一体化供应商。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026102300009480.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300639","BK0042","BK0132","BK0046","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2677937849","title":"股市必读：凯普生物新发布《关于回购股份结果暨股份变动的公告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2677937849","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2677937849?lang=zh_cn&edition=full","pubTime":"2026-10-23 03:00","pubTimestamp":1792695642,"startTime":"0","endTime":"0","summary":"当日关注点交易信息汇总：10月22日主力资金净流出493.95万元，占总成交额4.99%； 公司公告汇总：截至10月20日，凯普生物累计回购股份25,710,266股，占总股本3.98%，成交总金额149,994,498.63元，回购实施完毕。公司公告汇总关于回购股份结果暨股份变动的公告广东凯普生物科技股份有限公司于2026年7月23日召开董事会，审议通过以集中竞价交易方式回购公司股份的方案。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026102300002545.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0046","BK0042","BK0132","300639"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2677829670","title":"凯普生物（300639）披露回购股份结果暨股份变动的公告，10月21日股价下跌2.56%","url":"https://stock-news.laohu8.com/highlight/detail?id=2677829670","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2677829670?lang=zh_cn&edition=full","pubTime":"2026-10-21 22:22","pubTimestamp":1792592539,"startTime":"0","endTime":"0","summary":"截至2026年10月21日收盘，凯普生物报收于6.1元，较前一交易日下跌2.56%，最新总市值为39.44亿元。近日，广东凯普生物科技股份有限公司发布《关于回购股份结果暨股份变动的公告》。公告显示，公司于2026年7月23日召开董事会，审议通过以集中竞价交易方式回购公司股份的方案。本次回购符合方案及相关法规要求，回购股份将存放于公司回购专用证券账户，后续将用于出售或注销。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026102100041404.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0042","BK0132","300639","BK0239","BK0046"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2676630217","title":"凯普生物（300639）10月19日主力资金净卖出48.64万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2676630217","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2676630217?lang=zh_cn&edition=full","pubTime":"2026-10-20 09:19","pubTimestamp":1792459156,"startTime":"0","endTime":"0","summary":"证券之星消息，截至2026年10月19日收盘，凯普生物报收于5.7元，下跌2.9%，换手率2.23%，成交量14.04万手，成交额7998.12万元。近5日资金流向一览见下表：凯普生物融资融券信息显示，融资方面，当日融资买入854.4万元，融资偿还610.65万元，融资净买入243.75万元。凯普生物主营业务：围绕人民健康开展,属于生物医药领域中的体外诊断领域,是分子诊断产品和服务的一体化供应商。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026102000006509.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0046","BK0042","BK0132","300639"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2674812686","title":"凯普生物最新公告：全资子公司取得医疗器械注册证书","url":"https://stock-news.laohu8.com/highlight/detail?id=2674812686","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2674812686?lang=zh_cn&edition=full","pubTime":"2026-10-11 17:20","pubTimestamp":1791710449,"startTime":"0","endTime":"0","summary":"凯普生物(300639.SZ)公告称，公司全资子公司潮州凯普生物化学有限公司取得国家药品监督管理局颁发的医疗器械注册证，产品为阴道微生物核酸检测试剂盒(PCR-荧光探针法)，属III类体外诊断试剂，用于定性检测阴道分泌物中的阴道毛滴虫、阴道加德纳菌及白色念珠菌核酸。以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026101100006161.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK1100","159883","BK1574","BK0042","BK0132","BK1583","09996","BK0046","BK0239","300639"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673014062","title":"股市必读：凯普生物新发布《关于2026年以集中竞价交易方式回购公司股份的进展公告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2673014062","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2673014062?lang=zh_cn&edition=full","pubTime":"2026-10-08 01:36","pubTimestamp":1791394571,"startTime":"0","endTime":"0","summary":"公司公告汇总：截至9月30日，凯普生物已累计回购股份21,573,566股，占总股本3.34%，支付资金总额124,999,575.45元，回购进展符合方案规定。公司公告汇总关于2026年以集中竞价交易方式回购公司股份的进展公告广东凯普生物科技股份有限公司于2026年7月23日召开董事会，审议通过以集中竞价交易方式回购公司股份的方案，回购资金总额不低于7,500万元且不超过15,000万元，回购价格不超过7.84元/股，资金来源为自有资金和银行专项回购贷款。回购期限将于2026年10月22日届满。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026100800000919.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0132","BK0042","BK0239","300639","BK0046"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671222983","title":"凯普生物（300639）9月29日主力资金净卖出1332.77万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2671222983","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2671222983?lang=zh_cn&edition=full","pubTime":"2026-09-30 09:17","pubTimestamp":1790731079,"startTime":"0","endTime":"0","summary":"证券之星消息，截至2026年9月29日收盘，凯普生物报收于6.2元，下跌1.43%，换手率2.4%，成交量15.1万手，成交额9398.18万元。近5日资金流向一览见下表：凯普生物融资融券信息显示，融资方面，当日融资买入927.22万元，融资偿还646.8万元，融资净买入280.42万元。凯普生物主营业务：围绕人民健康开展,属于生物医药领域中的体外诊断领域,是分子诊断产品和服务的一体化供应商。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026093000007838.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0046","BK0239","BK0132","BK0042","300639"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671269745","title":"凯普生物（300639）9月28日主力资金净卖出1160.57万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2671269745","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2671269745?lang=zh_cn&edition=full","pubTime":"2026-09-29 09:07","pubTimestamp":1790644068,"startTime":"0","endTime":"0","summary":"证券之星消息，截至2026年9月28日收盘，凯普生物报收于6.29元，上涨1.13%，换手率3.39%，成交量21.36万手，成交额1.35亿元。近5日资金流向一览见下表：凯普生物融资融券信息显示，融资方面，当日融资买入1036.13万元，融资偿还1056.71万元，融资净偿还20.58万元。凯普生物主营业务：围绕人民健康开展,属于生物医药领域中的体外诊断领域,是分子诊断产品和服务的一体化供应商。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026092900008258.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0046","BK0132","BK0042","BK0239","300639"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669914865","title":"凯普生物(300639)9月18日股东户数3.42万户，较上期增加0.97%","url":"https://stock-news.laohu8.com/highlight/detail?id=2669914865","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2669914865?lang=zh_cn&edition=full","pubTime":"2026-09-22 17:37","pubTimestamp":1790069825,"startTime":"0","endTime":"0","summary":"证券之星消息，近日凯普生物披露，截至2026年9月18日公司股东户数为3.42万户，较9月10日增加328.0户，增幅为0.97%。在医疗器械行业个股中，凯普生物股东户数高于行业平均水平，截至9月18日，医疗器械行业平均股东户数为2.08万户。从股价来看，2026年9月10日至2026年9月18日，凯普生物区间涨幅为2.61%，在此期间股东户数增加328.0户，增幅为0.97%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026092200030528.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0042","BK0239","BK0046","300639","BK0132"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669194973","title":"凯普生物：截至2026年9月18日，公司股东总户数为34,181户","url":"https://stock-news.laohu8.com/highlight/detail?id=2669194973","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2669194973?lang=zh_cn&edition=full","pubTime":"2026-09-22 09:06","pubTimestamp":1790039166,"startTime":"0","endTime":"0","summary":"证券之星消息，凯普生物(300639)09月21日在投资者关系平台上答复投资者关心的问题。投资者提问：请问到9月20日止公司股东人数是多少？谢谢凯普生物回复：您好，感谢您的关注！截至2026年9月18日，公司股东总户数为34,181户。本文数据来源于深圳证券交易所互动易，仅供参考不构成投资建议。责任编辑：沈彬","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026092200006411.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0046","BK0132","BK0042","BK0239","300639"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667160827","title":"凯普生物：截至2026年9月10日，公司股东总户数为33,853户","url":"https://stock-news.laohu8.com/highlight/detail?id=2667160827","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2667160827?lang=zh_cn&edition=full","pubTime":"2026-09-16 15:03","pubTimestamp":1789542192,"startTime":"0","endTime":"0","summary":"证券之星消息，凯普生物(300639)09月16日在投资者关系平台上答复投资者关心的问题。投资者提问：您好，请问一下9月10号的股东人数是多少？谢谢凯普生物回复：您好，感谢您的关注！截至2026年9月10日，公司股东总户数为33,853户。本文数据来源于深圳证券交易所互动易，仅供参考不构成投资建议。责任编辑：沈彬","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026091600018715.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300639","BK0042","BK0132","BK0239","BK0046"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666553440","title":"股市必读：凯普生物新发布《关于参加2026年广东辖区投资者集体接待日暨辖区上市公司中报业绩说明会活动的公告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2666553440","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2666553440?lang=zh_cn&edition=full","pubTime":"2026-09-10 01:08","pubTimestamp":1788973692,"startTime":"0","endTime":"0","summary":"当日关注点交易信息汇总：9月9日主力资金净流出367.65万元，占总成交额8.25%； 公司公告汇总：凯普生物将于2026年9月15日通过网络远程方式参加广东辖区投资者集体接待日暨中报业绩说明会，投资者可提前提交问题。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026091000001828.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0132","BK0239","300639","BK0042","BK0046"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665936207","title":"股市必读：凯普生物(300639)股东户数3.41万户，较上期减少4.31%","url":"https://stock-news.laohu8.com/highlight/detail?id=2665936207","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2665936207?lang=zh_cn&edition=full","pubTime":"2026-09-07 01:27","pubTimestamp":1788715628,"startTime":"0","endTime":"0","summary":"截至2026年9月4日收盘，凯普生物报收于5.9元，下跌0.84%，换手率1.3%，成交量8.22万手，成交额4902.78万元。股本股东变化：截至2026年8月31日，凯普生物股东户数为3.41万户，较8月20日减少4.31%。股本股东变化股东户数变动截至2026年8月31日公司股东户数为3.41万户，较8月20日减少1535.0户，减幅为4.31%；户均持股数量由上期的1.81万股增加至1.9万股，户均持股市值为11.22万元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026090700000730.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0042","BK0046","300639","BK0239","BK0132"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664643333","title":"凯普生物(300639)8月31日股东户数3.41万户，较上期减少4.31%","url":"https://stock-news.laohu8.com/highlight/detail?id=2664643333","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2664643333?lang=zh_cn&edition=full","pubTime":"2026-09-04 17:36","pubTimestamp":1788514584,"startTime":"0","endTime":"0","summary":"证券之星消息，近日凯普生物披露，截至2026年8月31日公司股东户数为3.41万户，较8月20日减少1535.0户，减幅为4.31%。在医疗器械行业个股中，凯普生物股东户数高于行业平均水平，截至8月31日，医疗器械行业平均股东户数为2.09万户。从股价来看，2026年8月20日至2026年8月31日，凯普生物区间跌幅为5.88%，在此期间股东户数减少1535.0户，减幅为4.31%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026090400031027.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0042","BK0239","300639","BK0046","BK0132"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664238680","title":"凯普生物：截至2026年8月31日，公司股东总户数为34,098户","url":"https://stock-news.laohu8.com/highlight/detail?id=2664238680","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2664238680?lang=zh_cn&edition=full","pubTime":"2026-09-04 11:38","pubTimestamp":1788493100,"startTime":"0","endTime":"0","summary":"证券之星消息，凯普生物(300639)09月03日在投资者关系平台上答复投资者关心的问题。投资者提问：尊敬的董秘，您好！敬请发布截至今天8月31日公司的股东户数信息。谢谢！致礼！凯普生物回复：您好，感谢您的关注。截至2026年8月31日，公司股东总户数为34,098户。本文数据来源于深圳证券交易所互动易，仅供参考不构成投资建议。责任编辑：陈思雨","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026090400016841.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0132","BK0239","300639","BK0042","BK0046"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663000009","title":"凯普生物（300639）披露2026年以集中竞价交易方式回购公司股份的进展公告，8月31日股价下跌2.15%","url":"https://stock-news.laohu8.com/highlight/detail?id=2663000009","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2663000009?lang=zh_cn&edition=full","pubTime":"2026-08-31 22:22","pubTimestamp":1788186122,"startTime":"0","endTime":"0","summary":"截至2026年8月31日收盘，凯普生物报收于5.92元，较前一交易日下跌2.15%，最新总市值为38.27亿元。该股当日开盘6.02元，最高6.02元，最低5.87元，成交额达6305.66万元，换手率为1.69%。近日，广东凯普生物科技股份有限公司披露《关于2026年以集中竞价交易方式回购公司股份的进展公告》。本次回购符合相关法规及公司方案规定。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026083100037238.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0042","BK0046","300639","BK0239","BK0132"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662792847","title":"凯普生物(300639)8月20日股东户数3.56万户，较上期增加1.91%","url":"https://stock-news.laohu8.com/highlight/detail?id=2662792847","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662792847?lang=zh_cn&edition=full","pubTime":"2026-08-26 17:47","pubTimestamp":1787737655,"startTime":"0","endTime":"0","summary":"证券之星消息，近日凯普生物披露，截至2026年8月20日公司股东户数为3.56万户，较8月10日增加669.0户，增幅为1.91%。在医疗器械行业个股中，凯普生物股东户数高于行业平均水平，截至8月20日，医疗器械行业平均股东户数为2.13万户。从股价来看，2026年8月10日至2026年8月20日，凯普生物区间涨幅为6.79%，在此期间股东户数增加669.0户，增幅为1.91%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082600040258.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0046","BK0239","BK0042","BK0132","300639"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1793569188043,"stockEarnings":[{"period":"1week","weight":-0.0087},{"period":"1month","weight":-0.0934},{"period":"3month","weight":0.0306},{"period":"6month","weight":-0.0545},{"period":"1year","weight":0.007},{"period":"ytd","weight":0.0651}],"compareEarnings":[{"period":"1week","weight":-0.0248},{"period":"1month","weight":-0.0633},{"period":"3month","weight":-0.0609},{"period":"6month","weight":-0.1248},{"period":"1year","weight":-0.0973},{"period":"ytd","weight":-0.0932}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"广东凯普生物科技股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"34419人(较上一季度增加0.70%)","perCapita":"18309股","listingDate":"2017-04-12","address":"广东省潮州市湘桥区经济开发试验区北片高新区D5-3-3-4小区","registeredCapital":"64650万元","survey":" 广东凯普生物科技股份有限公司的主营业务是分子诊断产品、医学检验服务、医疗大健康服务。公司的主要产品是肿瘤检测、传染病检测、妇幼健康管理、出生缺陷防控、个体化精准用药。公司系宫颈癌筛查--HPV检测的先行者、倡导者，长期深耕妇科肿瘤早筛赛道，构建了国内品类最全、技术迭代领先的HPV检测产品矩阵，持续巩固宫颈癌早筛领域龙头地位，多款核心产品具备行业标杆性优势：HPV21分型检测试剂盒是我国首个取得新药证书的HPV检测产品，核心专利荣获第十八届中国专利金奖。","listedPrice":18.39},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.52.0","shortVersion":"4.52.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"凯普生物(300639)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供凯普生物(300639)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"凯普生物,300639,凯普生物股票,凯普生物股票老虎,凯普生物股票老虎国际,凯普生物行情,凯普生物股票行情,凯普生物股价,凯普生物股市,凯普生物股票价格,凯普生物股票交易,凯普生物股票购买,凯普生物股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"凯普生物(300639)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供凯普生物(300639)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}